Marek Borzestowski

NanoVelos SA engages in the development of nanodelivery drugs. The company was founded on March 15, 2013 and is headquartered in Wasraw, Poland.

NanoSanguis SA develops red blood cells substitutes which can alternate to natural blood. The company was founded by Agata Stefanek and Tomasz Ciach in December 2015 and is headquartered in Warsaw, Poland.

NanoThea SA develops radiopharmaceuticals for neoplastic diseases. It provides PET diagnosis and treatment of patients with metastatic tumours. The company was founded by Tomasz Ciach and Magdalena Janczewska in 2012 and is headquartered in Warsaw, Poland.

Giza Venture Capital (Giza Venture) is a venture capital firm founded in 1992 by Zeev Holtzman and Zvi Schechter. The firm is headquartered in Tel Aviv, Israel.

Giza Polish Ventures FIZ invests in companies located in Poland. The fund targets companies operating in the fields of telecommunications, media, internet, e-commerce, cleantech, mobile technologies, nanotechnologies and biotechnology. It provides financing for seed, early, later and growth stage capital requirements with an investment size of PLN 0.5-12 million. It prefers to acquire minority stakes and in some cases acquires majority stakes. It makes co-investments and also takes a seat on the board.